Top Abstract Purchase Related
Home
>
Node
>
Subnode

Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat

Sattler, M.; Guengerich, F.P.; Yun, C.H.; Christians, U.; Sewing, K.F.

Drug Metabolism and Disposition the Biological Fate of Chemicals 20(5): 753-761

1992

ISSN/ISBN: 0090-9556
PMID: 1385058
Document Number: 397121
The hepatic cytochrome P-450 responsible for metabolism of the structurally related macrolides FK506 and rapamycin in humans was identified using in vitro studies. FK506 and rapamycin metabolism was significantly correlated with nifedipine oxidation in human liver microsomes of eight different individuals. Immunoinhibition with anti-P450 3A4 abolished almost all FK506 and rapamycin metabolite formation. Inactivation of P450 3A4 by incubation of human liver microsomes with triacetyl oleandomycin (50 microM) or gestodene (10 microM) inhibited metabolism of FK506 and rapamycin. In liver microsomes from dexamethasone-treated rats FK506 and rapamycin metabolism was increased compared to liver microsomes from uninduced, phenobarbital-, or 3-methylcholanthrene-induced rats. FK506 and rapamycin were metabolized by reconstituted recombinant human liver P450 3A4. It is concluded that in human and rat liver FK506 and rapamycin are metabolized primarily by cytochrome P-450 3A4.

Document emailed within 1 workday
Secure & encrypted payments

Ackermann, E. 1978: Clinical pharmacologic aspects of cytochrome P-450 dependent biotransformation of drugs Die Pharmazie 33(7): 400-406
Keyes, S.R.; Fracasso, P.M.; Heimbrook, D.C.; Rockwell, S.; Sligar, S.G.; Sartorelli, A.C. 1984: Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1 Cancer Research 44(12 Pt 1): 5638-5643
Vickers, A.E.; Meyer, E.; Dannecker, R.; Keller, B.; Tynes, R.E.; Maurer, G. 1995: Human liver cytochrome P4503A biotransformation of the cyclosporin derivative SDZ IMM 125 Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(3): 321-326
Ortweiler, W.; Peiker, G.; Siegert, C.; Splinter, F.K.; Traeger, A. 1987: The effect of intrahepatic cholestasis in pregnancy on various forms of cytochrome P-450-dependent biotransformation reactions Die Pharmazie 42(5): 329-331
Cresteil, T.; Monsarrat, B.; Alvinerie, P.; Tréluyer, J.M.; Vieira, I.; Wright, M. 1994: Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation Cancer Research 54(2): 386-392
Campbell, M.E.; Grant, D.M.; Inaba, T.; Kalow, W. 1987: Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes Drug Metabolism and Disposition: the Biological Fate of Chemicals 15(2): 237-249
Subrahmanyam, V.; Renwick, A.B.; Walters, D.G.; Young, P.J.; Price, R.J.; Tonelli, A.P.; Lake, B.G. 2001: Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(8): 1146-1155
Hashizume, T.; Mise, M.; Matsumoto, S.; Terauchi, Y.; Fujii, T.; Imaoka, S.; Funae, Y.; Kamataki, T.; Miyazaki, H. 2001: A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(6): 798-805
Kalinina, E.V.; Obraztsov, V.V.; Shekhtman, D.G.; Gudkova, O.V.; Kukushkin, N.I.; Saprin, A.N. 1991: Effect of perfluorodecalin on activities of hepatic phase Ii xenobiotic biotransformation enzymes Biochemistry International 24(3): 543-548
Heimsch, E.; Dobler, T. 1980: A system for quality control of biotransformation enzymes in the mucosa of small intestine Journal of Clinical Chemistry and Clinical Biochemistry 18(11): 775-780
Foukis, A.; Stergiou, P.Y.; Filippou, M.; Koukouritaki, M.; Parapouli, M.; Theodorou, L.G.; Hatziloukas, E.; Afendra, A.; Pandey, A.; Papamichael, E.M. 2014: Kinetic constraints and features imposed by the immobilization of enzymes onto solid matrices: a key to advanced biotransformation Indian Journal of Experimental Biology 52(11): 1045-1051
Moto, K.-i.; Matsumoto, S. 2006: Biosynthetic enzymes responsible for sex pheromone production in Lepidoptera SEIKAGAKU. Journal of Japanese Biochemical Society 78(4): 317-321
Verschoyle, R.D.; Wolf, C.R.; Dinsdale, D. 1993: Cytochrome P450 2B isoenzymes are responsible for the pulmonary bioactivation and toxicity of butylated hydroxytoluene, O,O,S-trimethylphosphorothioate and methylcyclopentadienyl manganese tricarbonyl Journal of Pharmacology and Experimental Therapeutics 266(2): 958-963
Baede van Dijk, P.A.; de Graeff, P.A.; Lekkerkerker, J.F. 1999: Role of cytochrome P450 enzymes in pharmaceutical preparations Nederlands Tijdschrift Voor Geneeskunde 143(52): 2607-2611
Mlinarić-Galinović, G.; Zagar, Z. 1977: Procedure for the detection cytochrome-oxidase enzymes in bacteria Lijecnicki Vjesnik 99(8): 471-476
Shimada, T.; Guengerich, F.P. 1990: Inactivation of 1,3-, 1,6-, and 1,8-dinitropyrene by cytochrome P-450 enzymes in human and rat liver microsomes Cancer Research 50(7): 2036-2043
Ni, L.; Wang, D-wen. 2010: Association between cytochrome P450 enzymes metabolism and cardiovascular protection Zhonghua Xin Xue Guan Bing Za Zhi 38(4): 377-379
Vereczkey, L.; Jemnitz, K.; Monostory, K. 1997: Human liver cytochrome P-450 and conjugating enzymes. Hungarian data Acta Physiologica Hungarica 85(2): 149-152
Yamazaki, H.; Guo, Z.; Persmark, M.; Mimura, M.; Inoue, K.; Guengerich, F.P.; Shimada, T. 1994: Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes Molecular Pharmacology 46(3): 568-577
Williams, D.E.; Reed, R.L.; Kedzierski, B.; Dannan, G.A.; Guengerich, F.P.; Buhler, D.R. 1989: Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(4): 387-392